Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sherman

Showing results (911-920 of 1,275) with videos related to

Pageof 128
Sort By:
Stem Cells (Dayton, Ohio)|April 20, 2016
Brief Report: Elastin Microfibril Interface 1 and Integrin-Linked Protein Kinase Are Novel Markers of Islet Regenerative Function in Human Multipotent Mesenchymal Stromal CellsJessie R Lavoie, Marybeth M Creskey, Gauri Muradia, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 22, 2007
CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samplesJoseph D Carreon, Mark E Sherman, Diego Guillén, et al.
Pain Medicine (Malden, Mass.)|January 27, 2021
The Association Between Smoking Abstinence and Pain Trajectory Among Veterans Engaged in U.S. Department of Veterans Affairs Mental Health CarePatrick J Hammett, Michael S Businelle, Brent C Taylor, et al.
Pathogens & Immunity|August 13, 2024
Diagnostic Utility of Pre-Genomic Hepatitis B RNA in the Evaluation of HBV/HIV CoinfectionKenneth E Sherman, Susan D Rouster, Heidi Meeds, et al.
Hepatology (Baltimore, Md.)|April 16, 1998
Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trialK E Sherman, M Sjogren, R L Creager, et al.
International Journal of Cancer|August 9, 2011
Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatmentAimée R Kreimer, Mark Schiffman, Rolando Herrero, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 20, 2004
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa RicaRaphael P Viscidi, Mark Schiffman, Allan Hildesheim, et al.
Journal of the National Cancer Institute|October 15, 2010
Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infectionsMahboobeh Safaeian, Carolina Porras, Mark Schiffman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2025
Hepatitis B Vaccination Histories in Persons with HIV Needing RevaccinationMinhee Kang, Triin Umbleja, Anchalee Avihingsanon, et al.
Journal of the National Cancer Institute|February 10, 2015
Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancerSarah J Nyante, Mark E Sherman, Ruth M Pfeiffer, et al.
Pageof 128

Showing results (911-920 of 1,275) with videos related to

Sort By:
Pageof 128
Stem Cells (Dayton, Ohio)|April 20, 2016
Brief Report: Elastin Microfibril Interface 1 and Integrin-Linked Protein Kinase Are Novel Markers of Islet Regenerative Function in Human Multipotent Mesenchymal Stromal CellsJessie R Lavoie, Marybeth M Creskey, Gauri Muradia, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 22, 2007
CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samplesJoseph D Carreon, Mark E Sherman, Diego Guillén, et al.
Pain Medicine (Malden, Mass.)|January 27, 2021
The Association Between Smoking Abstinence and Pain Trajectory Among Veterans Engaged in U.S. Department of Veterans Affairs Mental Health CarePatrick J Hammett, Michael S Businelle, Brent C Taylor, et al.
Pathogens & Immunity|August 13, 2024
Diagnostic Utility of Pre-Genomic Hepatitis B RNA in the Evaluation of HBV/HIV CoinfectionKenneth E Sherman, Susan D Rouster, Heidi Meeds, et al.
Hepatology (Baltimore, Md.)|April 16, 1998
Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trialK E Sherman, M Sjogren, R L Creager, et al.
International Journal of Cancer|August 9, 2011
Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatmentAimée R Kreimer, Mark Schiffman, Rolando Herrero, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 20, 2004
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa RicaRaphael P Viscidi, Mark Schiffman, Allan Hildesheim, et al.
Journal of the National Cancer Institute|October 15, 2010
Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infectionsMahboobeh Safaeian, Carolina Porras, Mark Schiffman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2025
Hepatitis B Vaccination Histories in Persons with HIV Needing RevaccinationMinhee Kang, Triin Umbleja, Anchalee Avihingsanon, et al.
Journal of the National Cancer Institute|February 10, 2015
Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancerSarah J Nyante, Mark E Sherman, Ruth M Pfeiffer, et al.
Pageof 128